Selected gene polymorphisms effect on skin and hair pigmentation in Polish children at the prepubertal age

Aneta Sitek1, Iwona Rosset1, Elżbieta Żądzińska1,2

  • 1Department of Anthropology, Faculty of Biology and Environmental Protection, University of Lodz, ul. Banacha 12/16, 90-237 Łódź, Poland e.zadzinska@biol.uni.lodz.pl iworos@biol.uni.lodz.pl.

Insights

Genetic variations in genes like HERC2 and SLC45A2 influence hair and skin pigmentation in Polish children. These findings can aid in predicting pigmentation phenotypes from DNA, particularly in forensic studies.

Area of Science:

  • Human Genetics
  • Dermatology
  • Forensic Science

Background:

  • Human pigmentation, including hair, skin, and iris color, undergoes changes during post-natal development.
  • Understanding the genetic basis of pigmentation is crucial for forensic applications, enabling DNA-based phenotype prediction.
  • Distinctive changes in hair pigmentation during ontogenesis highlight the importance of studying relevant genes.

Purpose of the Study:

  • To determine if genes associated with adult pigmentation influence the developing phenotype in prepubertal Polish children.
  • To investigate the association between specific single nucleotide polymorphisms (SNPs) and skin and hair color in children.
  • To assess the predictive potential of these SNPs for pigmentation traits.

Main Methods:

  • Study included 245 Polish children aged 7-10 years with normal pigmentation.
  • Skin melanin index (SMI) measured using a dermaspectrometer; hair color assessed using the Fischer-Saller scale.
  • Genotyping of five SNPs: rs1800401 (OCA2), rs35264875 (TPCN2), rs16891982 (SLC45A2), rs12913832 (HERC2), and rs1805007 (MC1R).
  • Statistical analysis using z-statistic and p-value; classifier performance evaluated by 10-fold cross-validation and AUC.

Main Results:

  • rs1800401 (MC1R) associated with light skin pigmentation (SMI<25th percentile).
  • rs16891982 (SLC45A2) associated with dark skin pigmentation (SMI>75th percentile).
  • rs12913832 (HERC2) and rs1800401 (OCA2) increased the probability of dark hair.
  • Other SNPs showed no significant association but improved prediction models.

Conclusions:

  • rs12913832 (HERC2) shows the strongest correlation with hair color, and rs16891982 (SLC45A2) with skin color in Polish children.
  • These polymorphisms can be components of predictive models for pigmentation in prepubertal European children.
  • Incorporating OCA2, TPCN2, and MC1R can enhance hair color prediction, while HERC2 and MC1R can improve skin color prediction models.
Abstract

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
63
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
94
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
73
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.9K
Epistasis01:39

Epistasis

In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...
51.0K
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
88